Mengmeng Zhang

North America Legal Chronicle. October 28, 2024

AvenCell Therapeutics’ $112 Million Series B Funding Round

By Leila Ahmed

Ropes & Gray represented AvenCell Therapeutics in the transaction, and Wilson Sonsini Goodrich & Rosati advised Novo Holdings and F-Prime Capital on the transaction. AvenCell Therapeutics...

Standard 1 Year Membership Required

You must be a Standard 1 Year member to access this content.

Join Now

Already a member? Log in here

Novo Nordisk’s $2 Billion License Agreement with United Laboratories

LaCAR’s Acquisition of Newborn Screening Division

LogProStyle’s $10 Million IPO

Addi’s $170 Million Credit Facility

Ransa Group’s $150 Million Financing from International Finance Corporation

Origem Camponesa, COPTIL, and COOPERBIO’s R$3.2 Million Agribusiness Receivables Certificates Issuance

Anatom’s Acquisition of Additional Shares in BioGaia

CTS Group’s Bonds Offering

Sparbanksstiftelsen Rekarne’s Merger Between Savings Banks

2PointZero’s Acquisition of Maseera Holding

Hyde Park Developments’ EGP2.6 Billion Medium-Term Financing

SolarAfrica Energy’s Financing of 114 MW SunCentral 1 PV Plant and Main Transmission Substation

Entaj’s US$120 Million Initial Public Offering

SALIC’s US$1.78 Billion Acquisition of Additional Stake in Olam Agri

Hassana Investment Company’s Acquisition of 40% Stake in Berain Water Company

Plus500’s Acquisition of Mehta Equities Limited

TPG’s Acquisition of a Majority Stake in Indian Wind Turbine Business of Siemens Gamesa

DBS Group Holdings Ltd’s $2 Billion Multi-Series Senior Bond Issuance

Advancing ADR In Miami: JAMS and Arbitration Place Launch Strategic Collaboration

Womble Bond Dickinson’s Strategic Alliance With Schmidt, Valois, Miranda, Ferreira & Agel

What Is the Average Bicycle Accident Claim?

Morrison Foerster Expands Bicoastal Tech M&A Capabilities with Arrival of Partner Scott Behar in New York

Veirano Advogados Expands National Presence With New Office in Belo Horizonte

Janelle Iturbe Joins Quarles Phoenix Office as Partner in Real Estate Group

AvenCell Therapeutics’ $112 Million Series B Funding Round

Standard 1 Year Membership Required